세계의 약제 스크리닝 시장은 예측 기간(2026-2036년)에서 CAGR 11.8%로 성장하며, 2026년 82억 9,000만 달러에서 2036년까지 약 253억 달러에 달할 것으로 전망되고 있습니다.
세계의 약물 스크리닝(Drug Screening) 시장에 대해 조사 분석했으며, 5개 주요 지역의 현재 시장 동향, 시장 규모, 최근 동향, 2036년까지의 예측에 초점을 맞추어 상세하게 조사 분석하여 전해드립니다. 광범위한 2차 및 1차 조사와 시장 시나리오에 대한 심층 분석을 통해 주요 산업 촉진요인, 억제요인, 기회 및 과제에 대한 영향 분석을 수행했습니다.
약물 스크리닝 시장의 성장을 이끄는 주요 요인으로는 직장 안전에 대한 전 세계적인 관심 증가, 종합적인 약물 남용 방지 프로그램의 급속한 확대, 교통 기관 및 의료시설에서 신뢰할 수 있는 약물 검출의 필요성 증가 등이 있습니다. 또한 구강액 검사의 보급, 신속 검사 시스템의 혁신, 규제 준수 인프라의 개발은 약물 스크리닝 시장에서 사업을 운영하는 기업에게 큰 성장 기회를 창출할 것으로 예측됩니다.
Drug Screening Market by Product (Analyzers, Rapid Testing Devices, Consumables, Services), Sample Type (Urine, Oral Fluid, Breath, Hair), Technology (Immunoassay, Chromatography, Breath Analyzers), End User (Workplace, Drug Testing Laboratories, Hospitals, Criminal Justice, Drug Treatment Centers), and Application (Drug of Abuse Testing, Alcohol Testing) - Global Forecast to 2036
According to the research report titled, 'Drug Screening Market by Product (Analyzers, Rapid Testing Devices, Consumables, Services), Sample Type (Urine, Oral Fluid, Breath, Hair), Technology (Immunoassay, Chromatography, Breath Analyzers), End User (Workplace, Drug Testing Laboratories, Hospitals, Criminal Justice, Drug Treatment Centers), and Application (Drug of Abuse Testing, Alcohol Testing) - Global Forecast to 2036,' the global drug screening market is expected to reach approximately USD 25.3 billion by 2036 from USD 8.29 billion in 2026, at a CAGR of 11.8% during the forecast period (2026-2036).
The report provides an in-depth analysis of the global drug screening market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2036. Following extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges.
The major factors driving the growth of the drug screening market include escalating global concern over workplace safety, rapid expansion of comprehensive substance abuse prevention programs, and increasing need for high-reliability detection in transportation and healthcare complexes. Additionally, proliferation of oral fluid testing, innovation in rapid testing systems, and regulatory compliance infrastructure development are expected to create significant growth opportunities for players operating in the drug screening market.
The drug screening market is segmented by product (analyzers, rapid testing devices, consumables, services), sample type (urine, oral fluid, breath, hair), technology (immunoassay, chromatography, breath analyzers), end user (workplace, drug testing laboratories, hospitals, criminal justice, drug treatment centers), application (drug of abuse testing, alcohol testing), and geography. The study also evaluates industry competitors and analyzes the market at the country level.
Based on Product
By product, the services segment holds the largest market share in 2026, particularly in supporting large-scale laboratory testing operations, comprehensive workplace programs, and superior analytical accuracy in forensic applications. Analyzers represent a significant segment for confirmatory testing and high-volume screening. Rapid testing devices are growing rapidly for point-of-care applications and on-site screening. Consumables represent a steady segment supporting ongoing testing operations.
Based on Sample Type
By sample type, the urine sample segment holds the largest market share in 2026, due to the widespread adoption of standardized testing protocols and established detection windows for diverse substance categories. Oral fluid represents a rapidly growing segment offering improved sample integrity and non-invasive collection. Breath and hair samples represent specialized segments for specific applications and extended detection windows.
Based on Technology
By technology, immunoassay dominates the market for rapid screening applications, offering cost-effectiveness and high-throughput capabilities. Chromatography represents a significant segment for confirmatory testing and complex substance detection. Breath analyzers represent a specialized segment for alcohol testing and impairment assessment. Advanced analytical technologies continue to evolve for improved detection accuracy and expanded substance coverage.
Based on End User
By end user, the workplace segment holds the largest share of the overall market in 2026, driven by stringent regulatory requirements and comprehensive occupational health protocols. Drug testing laboratories represent a significant segment for confirmatory testing and forensic applications. Hospitals, criminal justice systems, and drug treatment centers represent growing segments with specialized testing requirements and regulatory compliance needs.
Geographic Analysis
An in-depth geographic analysis of the industry provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. North America dominates the global drug screening market with the largest market share in 2026, driven by stringent workplace regulations and the presence of comprehensive federal testing programs in the United States and Canada. Asia-Pacific is expected to witness the fastest growth during the forecast period, supported by increasing awareness of substance abuse prevention and expanding workplace safety protocols in China, India, and Japan.
Key Players
The key players operating in the global drug screening market are Quest Diagnostics, LabCorp, Abbott Diagnostics, Thermo Fisher Scientific, Alere Inc., Roche Diagnostics, Siemens Healthcare Diagnostics, Bio-Rad Laboratories, Immunalysis Corporation, and Psychemedics Corporation, among others.
Key Questions Answered in the Report
Drug Screening Market Assessment -- by Product
Drug Screening Market Assessment -- by Sample Type
Drug Screening Market Assessment -- by Technology
Drug Screening Market Assessment -- by End User
Drug Screening Market Assessment -- by Application
Drug Screening Market Assessment -- by Geography